Concepedia

Publication | Open Access

384P BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC

DOIFull Paper Access

12

Citations

0

References

2020

Year

Stefanie S. Schalm, Tom Dineen, Sangbin Lim, C.W. Park, John Hsieh, Rich Woessner, Z. Zhang, Kevin Wilson, Meredith S. Eno, Douglas Wilson,
Annals of Oncology

No additional data available for this publication yet. Check back later!